Clin2
NCT07017946Possibly a fitRecruiting

Gut bacteria transplant for fast-progressing ALS

Amyotrophic Lateral Sclerosis ALS

Part of Brain & nervous system, Hormones & metabolism clinical trials.

This trial tests whether a transplant of healthy gut bacteria (called a microbiome transplant) can slow down ALS in people whose disease is progressing rapidly. It aims to see if changing the gut environment can help with symptoms and quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a definite ALS diagnosis, and your disease is progressing quickly (a drop of 1.5 or more points per month on the ALSFRS-R scale).
  • You are at least 18 years old.
  • Your ALS symptoms are moderate (ALSFRS-R score of 24 or higher), and you can swallow capsules.
  • You have been on a stable dose of riluzole, edaravone, or tofersen for at least 30 days, or you are not taking any of these and don't plan to during the study.
  • You have not taken antibiotics in the last 3 months, probiotics or herbal supplements in the last 2 weeks, or any other investigational drug in the last 30 days.
  • You are not pregnant, and if sexually active, you agree to use contraception.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07589764Not yet recruiting· Phase 1
Testing a muscle supplement to lower a blood marker in ALS

This pilot study tests whether a muscle-supporting supplement called HMB can lower a blood marker (IGFBP7) that may be related to ALS. The goal is to see if this supplement is safe and could be a helpful addition to usual care for people with ALS.

Durham, North Carolina
NCT06671236Recruiting· Phase 1
Treg cell therapy for ALS

This trial tests a new type of cell therapy called regulatory T cells (Tregs) for people with neurodegenerative diseases like ALS. The goal is to see if these cells can slow down the disease.

Zhengzhou, Henan
NCT07369076Recruiting· Phase 1/Phase 2
Testing NB-4746 for people with ALS

This study tests an investigational drug called NB-4746 for people with ALS. The goal is to see if it can slow the progression of the disease. It is for people diagnosed within the last couple of years who are still able to eat and breathe on their own.

Concord, New South Wales
NCT06051123Recruiting
Probiotics for ALS and related disorders

This trial tests whether probiotics (healthy bacteria) can help people with ALS. You'll take a probiotic or placebo daily for several months, and researchers will track your symptoms and gut health.

Fredericton, New Brunswick
NCT06771414Not yet recruiting
Gut bacteria study for people with ALS

This study looks at the bacteria in your gut (microbiome) to see if they are linked to different symptoms or types of ALS. It may help doctors understand more about the disease and could lead to better treatments in the future.

NCT07539662Enrolling by invitation
Cord Blood Stem Cell Transplant for ALS

This trial tests whether a transplant of special cells from donated umbilical cord blood can help slow or improve symptoms of ALS (amyotrophic lateral sclerosis, also called Lou Gehrig's disease). The cells may help repair nerve damage and reduce disease progression.

Tianjin

Hear when a new Amyotrophic Lateral Sclerosis ALS trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.